Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Gago

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Modelling and simulation: a computational perspective in anticancer drug discoveryFederico Gago
Marine Drugs|February 24, 2023
Computational Approaches to Enzyme Inhibition by Marine Natural Products in the Search for New DrugsFederico Gago
Future Medicinal Chemistry|October 24, 2012
Molecular simulations of drug-receptor complexes in anticancer researchFederico Gago
Journal of Computer-Aided Molecular Design|December 22, 2011
Reflections on the past 25 yearsFederico Gago
Journal of Computer-Aided Molecular Design|January 18, 2020
Atomistic insight into sequence-directed DNA bending and minicircle formation propensity in the absence and presence of phased A-tractsAlberto Mills, Federico Gago
International Journal of Molecular Sciences|July 2, 2021
On the Need to Tell Apart Fraternal Twins eEF1A1 and eEF1A2, and Their Respective OutfitsAlberto Mills, Federico Gago
Journal of Computer-Aided Molecular Design|June 27, 2003
Current perspective of information technologies in drug discoveryFerran Sanz, Federico Gago
Chemmedchem|September 7, 2007
Overcoming the inadequacies or limitations of experimental structures as drug targets by using computational modeling tools and molecular dynamics simulationsEsther Marco, Federico Gago
Molecular Pharmacology|September 10, 2005
DNA structural similarity in the 2:1 complexes of the antitumor drugs trabectedin (Yondelis) and chromomycin A3 with an oligonucleotide sequence containing two adjacent TGG binding sites on opposing strandsEsther Marco, Federico Gago
Current Opinion in Biotechnology|October 29, 2013
New horizons in pharmaceutical biotechnology by melding biology and engineeringAjikumar Parayil, Federico Gago
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Modelling and simulation: a computational perspective in anticancer drug discoveryFederico Gago
Marine Drugs|February 24, 2023
Computational Approaches to Enzyme Inhibition by Marine Natural Products in the Search for New DrugsFederico Gago
Future Medicinal Chemistry|October 24, 2012
Molecular simulations of drug-receptor complexes in anticancer researchFederico Gago
Journal of Computer-Aided Molecular Design|December 22, 2011
Reflections on the past 25 yearsFederico Gago
Journal of Computer-Aided Molecular Design|January 18, 2020
Atomistic insight into sequence-directed DNA bending and minicircle formation propensity in the absence and presence of phased A-tractsAlberto Mills, Federico Gago
International Journal of Molecular Sciences|July 2, 2021
On the Need to Tell Apart Fraternal Twins eEF1A1 and eEF1A2, and Their Respective OutfitsAlberto Mills, Federico Gago
Journal of Computer-Aided Molecular Design|June 27, 2003
Current perspective of information technologies in drug discoveryFerran Sanz, Federico Gago
Chemmedchem|September 7, 2007
Overcoming the inadequacies or limitations of experimental structures as drug targets by using computational modeling tools and molecular dynamics simulationsEsther Marco, Federico Gago
Molecular Pharmacology|September 10, 2005
DNA structural similarity in the 2:1 complexes of the antitumor drugs trabectedin (Yondelis) and chromomycin A3 with an oligonucleotide sequence containing two adjacent TGG binding sites on opposing strandsEsther Marco, Federico Gago
Current Opinion in Biotechnology|October 29, 2013
New horizons in pharmaceutical biotechnology by melding biology and engineeringAjikumar Parayil, Federico Gago
Pageof 18